World's 1st Swivel Biopsy Test For Detection And Prevention Of Oral Cancer


(MENAFNEditorial) Javed Jaffrey , Ali Asghar, Nausheen Ali Sardar, Ratan Rajput and Akbar Sami did the honours for Dr. Zahra Hussaini at Nanavati Hospital by launching the ' C TEST ' for cancer , the world's first swivel biopsy test for detection and prevention of oral cancer. They pledged their support to Dr. Zahra and her team in taking this path breaking innovation forward. Viveck Shettyy , Motivational Speaker and singer , personally hosted this spectacular launch in his trademark flamboyant style with great wit and humour.

Patients like Sangeeta Kulkarni shared their real life experiences with Dr. Zahra and their journey back to health and wellness . Dr. Ali Irani , reputed physiotherapist , was all part of this exclusive gathering . The first C test kit was also unveiled and backed by an effective demonstration of the simple easy to use format of the kit. Dr. Zahra Hussaini emphatically stated , " It is my vision and dream to take the C Test to the deepest rural areas of India and eliminate the threat of oral cancer. "

The early detection and prevention of oral cancer can now become a reality thanks to decades of hard work and research and some pioneering work by Dr. Zahra Hussaini, The ' C TEST' as she chooses to call it is an unique test that comprises of two tests that can be done with one simple, easy to use kit.

The CYTO TEST (brush biopsy as compared to pap smear) is one part of it and the other is the C SWIVEL BIOPSY ( a modified punch biopsy). The major advantages of the C TESTare its simple design , easy to use format , digitalised reporting pattern and a turnaround time of 3 days . More importantly at a very cost effective price that is easily affordable to all sections of society.

The other technical advantage is the high rate of accuracy owing to the dual test format ( brush & swivel). It is also simple. painless , easy to use and does not require anesthetic or suturing. This test has been specifically developed for oral cancer and is completely sterile with disposable tips and also easy packaging for transportation of biopsy sample.

According to the WHO,Oral cancer is a major health problem worldwide. Among modern epidemics, cancer is the second commonest cause of mortality in developed countries. Oral cancer ranks number one among men and number three among women in India. Oral cancer constitutes 12% of all cancers in men and 8% of all cancers among women. It was estimated that in the year 2000, worldwide over 10 million new cases of cancer occurred (approximately 5.3 million men and 4.7 million women) and over 6 million people died from cancers.


According to Dr. Zahra Hussaini, Unlike many projects, The C test Oral Cancer Project & Charity will be focused on solving a single problem: reducing the mortality rate of Oral Cancer worldwide. Oral Cancer is the number one cause of death among all cancers in India and there is - one death every 7 minutes. Most sufferers are in the rural areas, where they lack awareness and have minimal access to advanced medical care. In USA there is a death every hour only due to oral cancer.

Dr. Zahra wants to bring to India a total solution for reducing deaths due to oral cancer. a solution for India by an Indian using Indian technology & provided at Indian prices. so is not just about another test for detecting oral cancer but a total turnkey concept- early detection test, general public awareness, doctors training( Dentist, Ent Surgeon, Physician, Auxilliary Staff) and specific oral cancer charity .
Contact Information

  • Name: Ali khan

    Company: Indusi Communication

    Telphone: 91-022-66912814 , 91-9821555668

    Address: 203 Patel Estate

    Email:

    MENAFN0312201700703206ID1096179762


    ForPressRelease

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

    Newsletter